The monthly number of ezetimibe prescriptions/100 ,000 population rose from 6 to 1,082 in the US from November 2002 to January 2008 , then significantly declined to 572/100 ,000 population by December 2009 after the release of the ENHANCE trial , a decrease of 47.1 % ( P < .001 ) .